HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

New culture system confirms amyloid theory, can revolutionize drug discovery for Alzheimer's disease

An innovative laboratory culture system has succeeded, for the first time, in reproducing the full course of events underlying the development of Alzheimer's disease.

13 Oct 2014

Pharmaceutical industry withdraws from the antibiotic space

The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive.

13 Oct 2014

HIV-infected users of stimulants derive benefits from antiretroviral therapy

New clinical research from UC San Francisco shows that 341 HIV-infected men who reported using stimulants such as methamphetamine or cocaine derived life-saving benefits from being on antiretroviral therapy that were comparable to those of HIV-infected men who do not use stimulants.

13 Oct 2014

Grand Challenges Canada announces 11 seed grants to improve mental health in developing countries

On the day the world is collectively raising awareness on mental health issues, Grand Challenges Canada, funded by the Government of Canada, announced new funding for 11 novel ideas to improve mental health in developing countries, one of the biggest unmet needs of our time. Seed grants of up to $270,000 are awarded to 11 innovators from Canada and low- and middle-income countries, totalling $2.9 million CAD.

10 Oct 2014

KNCV becomes prime partner for USAID's flagship tuberculosis program

KNCV Tuberculosis Foundation, the Dutch NGO specialized in the fight against tuberculosis, will be the prime partner for the United States Agency for International Development in their new five year flagship program 'Challenge TB'.

9 Oct 2014

Revolutionary Hypo-tec Needlestick Injury Prevention Product enters North American market

V3 Healthcare Strategies, a Wisconsin-based Accountable Care Strategies company, announced the North American launch of the revolutionary Hypo-tec Needlestick Injury Prevention Product amidst an environment of infectious catastrophic diseases such as Ebola, Hanta & Hemorrhagic Fevers, while simultaneously protecting against all other infectious diseases such as HIV/AIDS, Hepatitis and more.

8 Oct 2014

Viewpoints: Relatively few face insurance cancellations; new doctor payment site is 'impenetrable'

People are starting to get letters telling them their health insurance plans have been canceled because of the Affordable Care Act. Because the letters will go out just before the midterm congressional elections, they are likely to get a lot of attention. There have been several stories this past week. But the people affected will represent only a small fraction of the population with health insurance (Margot Sanger-Katz, (10/6).

8 Oct 2014

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

The international research & development (R&D) consortium, AfriCoLeish, formed by six research organizations from East Africa and Europe, has launched a Phase III clinical study to address the extreme difficulty in treating visceral leishmaniasis (VL) in patients who also are HIV-positive.

6 Oct 2014

Vitamin D supplement significantly reduces symptoms of winter-related atopic dermatitis

A study conducted in more than 100 Mongolian schoolchildren found that daily treatment with a vitamin D supplement significantly reduced the symptoms of winter-related atopic dermatitis, a type of eczema.

5 Oct 2014

Genetic history of HIV finally unravelled

Research, published today, shows that the HIV pandemic almost certainly began its global spread in the 1920s in Kinshasa in the Democratic Republic of Congo.

3 Oct 2014

Gaucher disease: an interview with Dr Clement Olivier, Shire

Gaucher disease is the most common condition within a family of rare diseases known as the lysosomal storage diseases. The disease causes lipids to accumulate in cells, which is why it is referred to as a storage disorder. The accumulation occurs mainly in the spleen, liver, and bones, but may also occur in the lungs, heart, and central nervous system.

30 Sep 2014

Gut microbe in patients may tip doctors about SCID

Many people recognize "the bubble boy" as an unusual character from a "Seinfeld" episode or a John Travolta movie.

30 Sep 2014

UCSF gets CDC grant to provide expert guidance to clinicians who prescribe anti-HIV medications

The UCSF Clinician Consultation Center at San Francisco General Hospital and Trauma Center has been funded by the Centers for Disease Control and Prevention to provide a PrEPline, a telephone consultation service that gives expert guidance to healthcare providers across the nation who prescribe antiretroviral medications to HIV uninfected individuals to prevent HIV.

30 Sep 2014

New report urges nations to adopt improved data collection efforts for community health workers

A new report finds that developing nations' ability to deal with pressing health challenges like HIV/AIDS and ensuring maternal and newborn survival will be strengthened by creating a common definition for community health workers, as well as a core set of skills and competencies that would help ensure they are optimally trained, supported and deployed to provide care and treatment when and where it is needed most.

29 Sep 2014

Many gay, bisexual men complacent about HIV testing

Gay and bisexual men say HIV is the No. 1 health issue facing their community, but just 30 percent say they were tested for the virus within the last year as recommended. Another 30 percent say they have never been tested, according to a survey by the Kaiser Family Foundation.

26 Sep 2014

Research findings provide clues for design of future HIV vaccine

Scientists at The Scripps Research Institute have described how a single family of antibodies that broadly neutralizes different strains of HIV has evolved remarkably diverse structures to attack a vulnerable site on the virus.

26 Sep 2014

New NIH program awards $2.5 million to spur innovation in mobile health

A new NIH program is awarding nearly $2.5 million to spur innovation in mobile communication technologies and software applications used in biomedical research in low- and middle-income countries (LMICs).

25 Sep 2014

Many fear lack of confidentiality and disclosure regarding genetic test's purpose

Genomic medicine is rapidly developing, bringing with its advances promises of individualized genetic information to tailor and optimize prevention and treatment interventions. Genetic tests are already guiding treatments of the human immunodeficiency virus (HIV) and hepatitis c virus (HPC), and emerging research is showing genetic variants may be used to screen for an individual's susceptibility to addiction to a substance, and even inform treatments for addiction.

24 Sep 2014

State highlights: Medicaid bankruptcy ruling could save some nursing homes; high HIV rates in Southern states

A federal judge's recent ruling blocking Medicaid officials from cutting off a struggling nursing home could help troubled health care facilities survive using bankruptcy, according to restructuring professionals.

23 Sep 2014

Leidos awarded NMLC contract to provide services in support of HIV/AIDS prevention programs

Leidos, a national security, health, and engineering solutions company, was awarded a prime contract by the Naval Medical Logistics Command to provide services in support of the Naval Health Research Center's, Department of Defense, HIV/AIDS Prevention Program (DHAPP).

23 Sep 2014

HIV/AIDS News and Research

Further Reading

New culture system confirms amyloid theory, can revolutionize drug discovery for Alzheimer's disease

Pharmaceutical industry withdraws from the antibiotic space

HIV-infected users of stimulants derive benefits from antiretroviral therapy

Grand Challenges Canada announces 11 seed grants to improve mental health in developing countries

KNCV becomes prime partner for USAID's flagship tuberculosis program

Revolutionary Hypo-tec Needlestick Injury Prevention Product enters North American market

Viewpoints: Relatively few face insurance cancellations; new doctor payment site is 'impenetrable'

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

Vitamin D supplement significantly reduces symptoms of winter-related atopic dermatitis

Genetic history of HIV finally unravelled

Gaucher disease: an interview with Dr Clement Olivier, Shire

Gut microbe in patients may tip doctors about SCID

UCSF gets CDC grant to provide expert guidance to clinicians who prescribe anti-HIV medications

New report urges nations to adopt improved data collection efforts for community health workers

Many gay, bisexual men complacent about HIV testing

Research findings provide clues for design of future HIV vaccine

New NIH program awards $2.5 million to spur innovation in mobile health

Many fear lack of confidentiality and disclosure regarding genetic test's purpose

State highlights: Medicaid bankruptcy ruling could save some nursing homes; high HIV rates in Southern states

Leidos awarded NMLC contract to provide services in support of HIV/AIDS prevention programs

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News